Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Anticancer Research|October 2, 2019
Risk Factors for Poor Survival in Metastatic Castration-resistant Prostate Cancer Treated With Cabazitaxel in JapanShotaro Yasuoka, Takeshi Yuasa, Masahiro Ogawa, et al.
Anticancer Research|March 6, 2020
Phase II Study of Second-line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial CarcinomaMasahiro Ogawa, Shinya Yamamoto, Toru Inoue, et al.
Clinical Genitourinary Cancer|December 6, 2020
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With NivolumabRyo Fujiwara, Kosuke Takemura, Motohiro Fujiwara, et al.
Cancer Chemotherapy and Pharmacology|June 10, 2021
Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancerMotohiro Fujiwara, Takeshi Yuasa, Shotaro Yasuoka, et al.
International Journal of Clinical Oncology|September 16, 2019
Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancerRyo Fujiwara, Kentaro Inamura, Takeshi Yuasa, et al.
Anticancer Research|July 3, 2019
Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial CancerShotaro Yasuoka, Takeshi Yuasa, Noriko Nishimura, et al.
Anticancer Research|March 29, 2022
Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial CancerMotohiro Fujiwara, Ryo Fujiwara, Tetsuya Urasaki, et al.
Pageof 13